Elizabeth S.  Campbell net worth and biography

Elizabeth Campbell Biography and Net Worth

EVP of Cencora
Elizabeth Campbell is Executive Vice President and Chief Legal Officer for AmerisourceBergen Corporation. In this role, she is responsible for legal, regulatory, corporate security, global business resilience and enterprise risk management, and serves as the primary legal advisor for senior management and the Board of Directors.



Prior to becoming Chief Legal Officer, Ms. Campbell was Deputy General Counsel and Senior Vice President at AmerisourceBergen, where she oversaw the legal teams that support all of AmerisourceBergen’s businesses, corporate functions, and litigation. Ms. Campbell also served in a variety of roles with increasing responsibility during her career with AmerisourceBergen, including holding the positions of Chief Litigator and Chief Compliance Counsel.  

Ms. Campbell has more than 20 years of experience as a lawyer. Prior to joining AmerisourceBergen, she worked in private practice at a large law firm in its Pittsburgh and Philadelphia offices. Before law school, Ms. Campbell held various positions in executive education at the University of Pittsburgh.  
 
Ms. Campbell earned her juris doctor from the University of Pittsburgh.

What is Elizabeth S. Campbell's net worth?

The estimated net worth of Elizabeth S. Campbell is at least $2.02 million as of March 18th, 2024. Ms. Campbell owns 8,246 shares of Cencora stock worth more than $2,017,301 as of March 27th. This net worth evaluation does not reflect any other investments that Ms. Campbell may own. Additionally, Ms. Campbell receives an annual salary of $1,630,000.00 as EVP at Cencora. Learn More about Elizabeth S. Campbell's net worth.

How old is Elizabeth S. Campbell?

Ms. Campbell is currently 49 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Elizabeth S. Campbell's age.

What is Elizabeth S. Campbell's salary?

As the EVP of Cencora, Inc., Ms. Campbell earns $1,630,000.00 per year. There are 3 executives that earn more than Ms. Campbell. The highest earning executive at Cencora is Mr. Steven H. Collis, Chairman, President & CEO, who commands a salary of $5,010,000.00 per year. Learn More on Elizabeth S. Campbell's salary.

How do I contact Elizabeth S. Campbell?

The corporate mailing address for Ms. Campbell and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Elizabeth S. Campbell's contact information.

Has Elizabeth S. Campbell been buying or selling shares of Cencora?

During the last ninety days, Elizabeth S. Campbell has sold $1,661,363.24 in Cencora stock. Most recently, Elizabeth S. Campbell sold 6,977 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $238.12, for a transaction totalling $1,661,363.24. Following the completion of the sale, the executive vice president now directly owns 8,246 shares of the company's stock, valued at $1,963,537.52. Learn More on Elizabeth S. Campbell's trading history.

Who are Cencora's active insiders?

Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.

Are insiders buying or selling shares of Cencora?

During the last year, insiders at the sold shares 20 times. They sold a total of 7,564,215 shares worth more than $1,626,481,008.29. The most recent insider tranaction occured on March, 18th when EVP Elizabeth S Campbell sold 6,977 shares worth more than $1,661,363.24. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.

Information on this page was last updated on 3/18/2024.

Elizabeth S. Campbell Insider Trading History at Cencora

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2024Sell6,977$238.12$1,661,363.248,246View SEC Filing Icon  
2/3/2022Sell14,034$137.89$1,935,148.26View SEC Filing Icon  
See Full Table

Elizabeth S. Campbell Buying and Selling Activity at Cencora

This chart shows Elizabeth S Campbell's buying and selling at Cencora by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cencora Company Overview

Cencora logo
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $244.64
Low: $242.86
High: $244.68

50 Day Range

MA: $233.10
Low: $217.38
High: $244.64

2 Week Range

Now: $244.64
Low: $156.73
High: $244.68

Volume

674,290 shs

Average Volume

1,307,193 shs

Market Capitalization

$48.80 billion

P/E Ratio

26.65

Dividend Yield

0.84%

Beta

0.44